Plans for more independent prescribing progressing

March 9, 2005

Nurses could soon be able to independently prescribe for long-term conditions such as asthma and diabetes, under proposals being considered …

SSRI guidance unchanged, says MHRA

March 9, 2005
Sales and Marketing

UK regulator the MHRA has reiterated its guidance on SSRI antidepressants and stressed their safety after a new article linked …

Judge us on NHS record, says angry Blair

March 9, 2005

A row over a pensioner's repeatedly cancelled shoulder operation has escalated into a key election battle on the state of …

NHS Alliance warns of Health Check

March 9, 2005

The NHS Alliance has warned that the planned replacement to the controversial star ratings performance indicators may lead to 'perverse …

Heart progress trumpeted by Labour

March 9, 2005

The government has trumpeted its progress on tackling the UK's biggest killer, cardiovascular disease, and launched a new chapter of …

Potential blockbuster Tysabri pulled after patient death

March 9, 2005
Sales and Marketing

Elan and Biogen Idec have stopped marketing Tysabri (natalizumab), their new multiple sclerosis treatment, and asked doctors not to prescribe …

ABPI to oppose strictest measures in pan-European code of practice

March 3, 2005
Sales and Marketing

A pan-European code of practice is being drawn up by the pharmaceutical industry organisation EFPIA in response to continuing criticism …

GSK rebrands AIDS drugs to foil illegal imports

March 2, 2005
Sales and Marketing

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.The company said parallel importers …

Quicker service for cancer patients but ‘black spots’ persist

March 2, 2005

Cancer patients are being seen more quickly but there is still room for improvement, says a National Audit Office report …

NICE acts to speed lung cancer diagnosis and treatment

March 2, 2005

Patients showing symptoms of lung cancer should be offered an urgent referral to a chest physician, according to NICE recommendations …

Singulair gains dual asthma-hayfever indication

March 2, 2005
Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …

NHS is behind us, says rep-free Takeda

March 1, 2005
Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …

Cymbalta approved for second indication

February 24, 2005
Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …

Reassessing medical communications

February 24, 2005

It's time to be less defensive about perfectly legitimate medical communications methods providing contentious 'sharp practices' can be consigned to …

Sankyo and Daiichi set to continue Japanese consolidation

February 24, 2005
Sales and Marketing

Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …

FDA panel clears Vioxx return to market

February 21, 2005
Sales and Marketing

An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …

The Gateway to Local Adoption Series

Latest content